Abstract
Introduction: This brief review describes conservative treatment methods for pelvic venous congestion.
Therapy options: The authors present an analysis of the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs), ergot alkaloid derivatives, hormonal agents, venoprotective agents, and compression therapy in the treatment of pelvic congestion syndrome (PCS) as well as indications for medical therapy.
Conclusion: The paucity of studies addressing this topic and the need for large multidisciplinary studies to explore the opportunities for non-surgical treatment of PCS are highlighted.
Note
Transparency
Declaration of funding
Editorial assistance was funded by Servier International.
Author contributions: Both authors contributed to the concept and interpretation of the literature, were involved in the drafting and revising of the paper and approval of the final submitted version.
Declaration of financial/other relationships
S.G.G. and O.O.T. have disclosed that they have no significant relationships with or financial interests in any commercial companies related to this study or article.
CMRO peer reviewers on this manuscript have no relevant financial or other relationships to disclose.
Acknowledgments
Editorial assistance was provided by Jenny Grice, Bieuzy les Eaux, France.
Notes
1 Detralex is a registered trade name of Servier, Russia